Dagmar Valcarcel is an independent member of the Supervisory Board of Amedes Holding GmbH, a German medical diagnostics company. Until May 2025, she was an Independent Non-Executive Director of the Supervisory Board of Deutsche Bank AG, the chairwoman of the Regulatory Oversight Committee and a member of the Audit and Remuneration Committees.

She has been Non-Executive Chairwoman of the Management Board of Andbank Asset Management Luxembourg SA, a member of the General Council of the Hellenic Financial Stability Fund (Special Purpose Vehicle owned by Greece to stabilise the Greek financial sector and to manage the Republic’s equity participations in Greece’s four systemic “too big to fail” banks) and Executive Chairwoman of the Management Board of Barclays Vida y Pensiones, Compañia de Seguros SAU, a Spanish life insurance company of the Barclays group.

From 2015 to 2017, Dagmar Valcarcel was Managing Director, Head of Strategic Resolution, Insurance Operations in the Chief Operating Office of Barclays Bank Plc’s Non-Core division, leading the divestment of Barclays’ insurance operations across Western Europe. Previously, she was General Counsel Western Europe, responsible for risk management and legal support to the Retail and Business Banking, Wealth and Investment Management and Corporate and Investment Banking divisions of Barclays throughout Continental Europe.

She joined Barclays in January 2010 from Terra Firma Capital Partners, where she was a Director in the Legal, Tax and Structuring Team. Prior to that role, she worked at Freshfields Bruckhaus Deringer, Clyde & Co and General & Cologne Re.

Dagmar Valcarcel holds a PhD in Law from Rheinische Friedrich-Wilhelms-Universität, Bonn (Germany) and is qualified in England, Wales, Germany and Spain. She is a Fellow of Studienstiftung des deutschen Volkes foundation.